240
Participants
Start Date
June 27, 2022
Primary Completion Date
March 31, 2025
Study Completion Date
April 30, 2025
Batoclimab 680 mg SC weekly
Batoclimab is a fully human anti-neonatal fragment crystallizable receptor (FcRn) monoclonal antibody
Batoclimab 340 mg SC weekly
Batoclimab is a fully human anti-neonatal fragment crystallizable receptor (FcRn) monoclonal antibody
Matching Placebo SC
Placebo
Batoclimab 340 mg SC bi-weekly
Batoclimab is a fully human anti-neonatal fragment crystallizable receptor (FcRn) monoclonal antibody
Site Number -7553, Budapest
Site Number - 9002, Niš
Site Number - 7552, Kistarcsa
Site Number - 5002, Buenos Aires
Site Number - 6503, Jena
Site Number -3505, Barcelona
Site Number - 6507, Berlin
Site Number - 9001, Belgrade
Site Number -3504, Córdoba
Site Number - 1021, Buffalo
Site Number - 6002, Genova
Site Number - 1023, Philadelphia
Site Number - 6003, Milan
Site Number - 6501, Hamburg
Site Number -1005, Charlottesville
Site Number - 6004, Bergamo
Site Number -6006, Brescia
Site Number - 1018, Chapel Hill
Site Number - 1008, Durham
Site Number -3503, Madrid
Site Number - 1030, Charleston
Site Number -1010, Maitland
Site Number -1019, Orlando
Site Number - 1020, Miami
Site Number -1017, Boca Raton
Site Number - 1015, Tampa
Site Number -1007, Clearwater
Site Number - 1028, Port Charlotte
Site Number - 1026, Memphis
Site Number -1003, Lexington
Site Number -4505, Daegu
Site Number -1004, Cleveland
Site Number - 6506, Bochum
Site Number -1013, East Lansing
Site Number - 1024, Minneapolis
Site Number -1011, Fairway
Site Number -1016, Dallas
Site Number - 1034, Houston
Site Number - 1014, Round Rock
Site Number -1001, Austin
Site Number - 1027, Aurora
Site Number - 6007, Napoli
Site Number -6001, Napoli
Site Number -1031, Murray
Site Number -1022, Phoenix
Site Number -1029, Scottsdale
Site Number - 1012, Olive View
Site Number -1002, Carlsbad
Site Number -1009, Irvine
Site Number -1032, San Francisco
Site Number -6502, Würzburg
Site Number -1006, Portland
Site Number -7503, Timișoara
Site Number -7501, Târgu Mureş
Site Number -7502, Constanța
Site Number - 1025, New Haven
Site Number - 5001, Buenos Aires
Site Number - 5003, Rosario
Site Number - 5501, Ribeirão Preto
Site Number- 5503, Rio de Janeiro
Site Number -2001, Edmonton
Site Number - 2003, Vancouver
Site Number - 2002, Toronto
Site Number - 2004, Montreal
Site Number -8002, Tbilisi
Site Number -8004, Tbilisi
Site Number -8001, Tbilisi
Site Number -8003, Tbilisi
Site Number - 8005, Tbilisi
Site Number -6504, Leipzig
Site Number -6005, Roma
Site Number - 4020, Asahikawa-shi
Site Number - 4014, Fuchu-shi
Site Number - 4002, Hanamaki-shi
Site Number - 4013, Higashimatsushima
Site Number - 4006, Kagawa
Site Number - 4009, Kawasaki-shi
Site Number - 4012, Koriyama-shi
Site Number - 4007, Koshigaya-shi
Site Number - 4011, Matsuyama
Site Number - 4008, Miyagi
Site Number - 4003, Narita-shi
Site Number - 4010, Osaka
Site Number - 4004, Osaka
Site Number - 4001, Osaka
Site Number - 4005, Tokyo
Site Number - 4018, Toyama
Site Number - 4016, Yokohama
Site Number - 4019, Yokohama
Site Number - 4015, Yokohama
Site Number - 4017, Yonago-shi
Site Number - 2601, Mexico City
Site Number - 3007, Gdansk
Site Number -3001, Katowice
Site Number -3004, Krakow
Site Number - 3003, Krakow
Site Number -3002, Krakow
Site Number - 3008, Lublin
Site Number -3006, Poznan
Site Number - 3005, Warsaw
Site Number -4501, Seoul
Site Number -3502, Barcelona
Site Number -3501, Madrid
Site Number - 7001, Liverpool
Site Number - 7002, Sheffield
Lead Sponsor
Immunovant Sciences GmbH
INDUSTRY